Finance

Beta
Lists
JSPR:NASDAQ
Jasper Therapeutics Inc
$0.34
0.00%
(0.00) 1D
$0.35
+2.64% (+0.0090)
Pre-market
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Mkt. cap
9.61M
Avg. vol.
622.24K
Volume
13.54K
52-wk high
$7.19
52-wk low
$0.34
EPS
-$3.23
Beta
3.00
Shares outstanding
28.01M
No. of employees
22
Mkt. cap
9.61M
Avg. vol.
622.24K
Volume
13.54K
52-wk high
$7.19
52-wk low
$0.34
EPS
-$3.23
Beta
3.00
Shares outstanding
28.01M
No. of employees
22
News stories
From sources across the web
About Jasper Therapeutics Inc
CEO-
Employees22
Founded2018
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websitejaspertx.com
Analyst ratings
Based on 6 analysts giving stock ratings to JSPR in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current $0.34
$20.00 (+5,765.10%)
Average
$7.88 (+2,210.85%)
Lowest
$1.50 (+339.88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Phipps
William Blair
Hold
Maintained
-
-
06/01/2026
Leonid Timashev
RBC Capital
Hold
Maintained
$3.00
+779.8%
05/14/2026
Yaron Werber
TD Cowen
Hold
Downgraded
-
-
05/15/2026
David Dai
UBS
Hold
Maintained
$1.50
+339.9%
04/02/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$7.00
+1,952.8%
04/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$20.00
+5,765.1%
03/30/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+4,885.3%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21.20M
13.10M
10.85M
5.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.88M
4.26M
4.49M
5.14M
Operating expense
27.08M
17.36M
15.35M
10.95M
Total operating expenses
27.08M
17.36M
15.35M
10.95M
Operating income
-27.08M
-17.36M
-15.35M
-10.95M
Other non operating income
-84.00K
88.00K
6.40M
9.61M
EBT including unusual items
-26.72M
-18.74M
-9.10M
-1.17M
EBT excluding unusual items
-26.72M
-16.93M
-8.61M
-1.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.72M
-18.74M
-9.10M
-1.17M
Net profit margin
-
-
-
-
Earnings per share
-1.74
-1.25
-0.54
-0.38
Interest and investment income
437.00K
342.00K
338.00K
164.00K
Interest expense
-
-
-
-
Net interest expenses
437.00K
342.00K
338.00K
164.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.82M
-17.13M
-15.06M
-10.93M
Gain or loss from assets sale
2.00K
-2.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of JSPR
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer